NVAX
Novavax, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +22.2% ·
share flow +14.0% ·
net new positions +18.2%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 11.37K | $125,080 | n/a | n/a |
| Q2 2026 | 98 | +3 | 79.12M | $745.13M | +11 | −8 |
| Q1 2026 | 98 | +8 | 80.71M | $656.76M | +12 | −4 |
| Q4 2025 | 89 | -3 | 88.45M | $594.43M | n/a | −3 |
| Q3 2025 | 19 | +2 | 55.31M | $479.50M | +2 | n/a |
| Q2 2025 | 14 | 0 | 51.16M | $322.31M | n/a | n/a |
| Q1 2025 | 11 | +1 | 21.46M | $137.59M | +1 | n/a |
| Q4 2024 | 10 | -2 | 20.61M | $165.71M | n/a | −2 |
| Q3 2024 | 11 | +2 | 17.18M | $216.96M | +2 | n/a |
| Q2 2024 | 9 | n/a | 15.07M | $190.77M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 5.94M | -6.1% | $74.99M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passive) | 3.50M | +9.5% | $44.25M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Coatue Management ✦ | 2.22M | -15.3% | $28.09M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 2.06M | +86.0% | $26.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.79M | +603.7% | $22.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 760.94K | +52.4% | $9.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 564.04K | -9.5% | $7.12M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 148.92K | -58.9% | $1.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 90.22K | +24.4% | $1.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 73.11K | New | $923,442 | 0.0% | New | 1 | SEC ↗ ×4 |
| 11 | AQR Capital Management ✦ | 18.76K | New | $236,901 | 0.0% | New | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $923,442 | 0.0% |
| AQR Capital Management | $236,901 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 100.30K shares, $816 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.